• A new gene identified in the search for a therapy to treat malignant cardiac arrhythmia
    A new gene identified in the search for a therapy to treat malignant cardiac arrhythmia Cardiac arrhythmias affect millions across the world and are responsible for around 15% of all deaths worldwide. Currently there are multiple treatment options, ranging from life-long medication to invasive surgical procedures. Research from Amsterdam UMC and Johns Hopkins University, published today in the European Heart Journal, sets another important step in the hunt for a one-off gene therapy that could improve heart function and protect against arrhythmias.
  • New medication sinus thrombosis just as safe but more patient-friendly
    New medication sinus thrombosis just as safe but more patient-friendly Patients affected by sinus thrombosis are treated with blood thinners. Traditionally, these patients are prescribed vitamin K antagonists (VKAs). In order to give the correct dosage, regular check-ups at the thrombosis service are necessary. A global study, coordinated by Amsterdam UMC, now shows that new medication, direct oral anticoagulants (DOACs), are equally safe and effective. The study was published today in The Lancet Neurology.
  • 'There is a lot of hunger for knowledge among policymakers'
    'There is a lot of hunger for knowledge among policymakers' Hoogleraar Vroege ontwikkeling en gezondheid Tessa Roseboom houdt zich al jaren bezig met de vraag hoe mensen gevormd worden door de omgeving waarin ze opgroeien, onder andere met het Hongerwinteronderzoek. De kennis die zij en haar collega-wetenschappers verzamelen, draagt ze actief uit. Dit kan beleidsmakers aan inzichten helpen om het leven van burgers, nu en in de toekomst, te verbeteren.

Amsterdam UMC is hiring

We are always on the lookout for talented and passionate people to join our growing team. You will have the opportunity to develop any aspects you are interested in.

See all our vacancies (in Dutch):

Job opportunities
Amsterdam UMC is hiring